MAPKAPK2 and thyroid gland papillary carcinoma: As we know, up to 70% of THCA were caused by mutations that activate the ERK signaling pathway32, and MK2 was strongly expressed in papillary thyroid carcinomas and follicular thyroid carcinomas cells33.